Real-world first-line treatment patterns and outcomes in recurrent/advanced endometrial cancer patients in Europe-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Real-world first-line treatment patterns and outcomes in recurrent/advanced endometrial cancer patients in Europe

Published:2024-08-09 Issue: Volume: Page:1-9
ISSN:1479-6694
Container-title:Future Oncology
language:en
Short-container-title:Future Oncology

Author:

Zhang Jingchuan¹,Kelkar Sneha S²,Prabhu Vimalanand S³,Ogando Yoscar M²,Verma Rishi P²^ORCID,Grall Véronique⁴,Marth Christian⁵

Affiliation:

1. Eisai Inc., RWE & HEOR, Nutley, NJ 07110, USA

2. OPEN Health, Evidence & Access, Bethesda, MD 20814, USA

3. Merck & Co., Inc., Merck Research Laboratories, Rahway, NJ 07065, USA

4. M3 (EU) Ltd., medeConnect, Abingdon, OX14 4RY, UK

5. Department of Obstetrics & Gynecology, Medical University Innsbruck, Innsbruck, A-6020, Austria

Funder

Eisai Incorporated

Merck

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14796694.2024.2379233

Reference25 articles.

1. The Global Cancer Observatory. Europe. Published March 2021. Accessed April 26 2023. https://gco.iarc.fr/today/data/factsheets/populations/908-europe-fact-sheets.pdf

2. Corpus uteri - international agency for research on cancer;The Global Cancer Observatory;Corpus Uteri.

3. Carcinoma of the corpus uteri

4. The nature of early-stage endometrial cancer recurrence—A national cohort study

5. Factors predicting recurrent endometrial cancer;Huijgens AN;Facts Views Vis Obgyn.,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP